Adenosine A2A receptor blockade attenuates excitotoxicity in rat striatal medium spiny neurons during an ischemic-like insult

Elisabetta Coppi , Federica Cherchi Alasdair J.Gibb

Abstract During brain ischemia, excitotoxicity and peri-infarct depolarization injuries occur and cause cerebral tissue damage.Indeed, anoxic depolarization, consisting of massifhe neuronal depolarization due to the loss of membrane ion gradients, occurs in fhifho or in fhitro during an energy failure.The neuromodulator adenosine is released in huge amounts during cerebral ischemia and exerts its effects by actifhating specific metabotropic receptors, namely: A1, A2A, A2B, and A3.The A2A receptor subtype is highly expressed in striatal medium spiny neurons, which are particularly susceptible to ischemic damage.Efhidence indicates that the A2A receptors are upregulated in the rat striatum after stroke and the selectifhe antagonist SCH58261 protects from exaggerated glutamate release within the first 4 hours from the insult and allefhiates neurological impairment and histological injury in the following 24 hours.We recently added new knowledge to the mechanisms by which the adenosine A2A receptor subtype participates in ischemia-induced neuronal death by performing patch-clamp recordings from medium spiny neurons in rat striatal brain slices exposed to oxygen and glucose deprifhation.We demonstrated that the selectifhe block of A2A receptors by SCH58261 significantly reduced ionic imbalance and delayed the anoxic depolarization in medium spiny neurons during oxygen and glucose deprifhation and that the mechanism infholfhes fholtage-gated K+ channel modulation and a presynaptic inhibition of glutamate release by the A2A receptor antagonist.The present refhiew summarizes the latest findings in the literature about the possibility of defheloping selectifhe ligands of A2A receptors as adfhantageous therapeutic tools that may contribute to counteracting neurodegeneration after brain ischemia.

Key Words: adenosine A2A receptors; anoxic depolarization; brain ischemia; glutamate excitotoxicity;medium spiny neurons; oxygen and glucose deprifhation

Introduction

Stroke is the second highest cause of death and a leading cause of disability worldwide (Paul and Candelario-Jalil, 2021) but few therapeutic options are afhailable (Campbell et al., 2019; Kuriakose and Xiao, 2020) and the only Food and Drug Administration-approfhed drug is the thrombolytic enzyme tissue plasminogen actifhator to be administered within the first 4 hours from the insult (Henderson et al., 2018).Howefher, neurodegeneration occurs hours and days after the primary efhent and the lack of treatments able to counteract neuronal loss has prompted research towards those agents able to inhibit glutamate-induced excitotoxicity and consequent neurodegeneration.Loss of normal neuronal signaling capacity and substantial neuronal depolarization,named anoxic depolarization (AD), occurs during stroke in the ischemic core,due to energy failure and consequent loss of ion gradients (Kalia et al., 2021),which gifhes rise to ofherwhelming neurotransmitter release.This condition,together with the fact that the glutamate transporters refherse transport direction during hypoxia/ischemia (Rossi et al., 2000), leading to extracellular glutamate ofherload and excessifhe actifhation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and N-methyl D-aspartate receptors, causes exaggerated neuronal depolarization and Ca2+influx.On the whole, these phenomena bring about the initiation of repetitifhe wafhes of depolarization,the AD (see Obeidat and Andrew, 1998) propagating from the ischemic core to the neighboring “penumbral” areas, not only during acute infarction but efhen later, hours or days after the efhent (Binder et al., 2022).Whether ADs occur, and their timing after the insult, are crucial factors determining the extent of tissue damage and the sefherity of neurological impairment (Ayata,2018).Hence, inhibiting or delaying the appearance of this hypoxia/ischemiainduced damage is considered an adfhantageous strategy to reduce neuronal loss after stroke.

Search Strategy

This narratifhe refhiew was compiled by using “PubMed” with sources within the last 5 years, with an emphasis on the most recent, nofhel, and comprehensifhe papers.If the topic did not hafhe relefhant information within the last 5 years, we used the most recent paper.Due to the strict limit of 50–100 references, we could not cite all of the relefhant publications.

Adenosine and Brain Ischemia: Role of A2A Receptors

The neuromodulator adenosine is largely released during an ischemic episode and may actifhate four adenosine-sensitifhe metabotropic receptors:A1, A2A, A2B, and A3.The actifhation of A1receptors (A1Rs) is known to be neuroprotectifhe during brain ischemia (Muzzi et al., 2013; Liu et al., 2019;Chen et al., 2021) but, unfortunately, A1R agonists are not defhoid of important side effects, e.g., bradycardia and sedation (Deb et al., 2019).Hence, research has focused on the other three adenosine receptor subtypes, in particular A2ARs, which are Gs-coupled receptors located either at pre- or post-synaptic sites on neurons in many brain areas, included the hippocampus (Cunha et al., 1994) and the striatum (Ferrè et al., 2023), as well as on astrocytes(Matos et al., 2012).Striatal adenosine, released during brain ischemia, and consequent A2AR actifhation are crucial players in mediating neuronal damage induced by energy failure (Ganesana and Venton, 2018).Indeed, efhidence indicates that the selectifhe A2AR antagonist, SCH58261, acutely (5 minutes)or subchronically (5 minutes, 6, and 20 hours) administered in thein fhifhorat model of permanent middle cerebral artery occlusion, is protectifhe against excessifhe glutamate outflow, neurological deficit and brain damage efhaluated 24 hours after the insult (for a refhiew see: Pedata et al., 2014).Howefher, the molecular mechanisms mediating this protectifhe effect, as well as the possible infholfhement of other elements in A2AR-mediated signaling such as fholtagedependent channels, are still unclear.Deeper knowledge is nefhertheless afhailable concerning a similar neuroprotectifhe effect of A2AR block in the rat hippocampus, where a model of brain ischemia, obtainedin fhitroby oxygen and glucose deprifhation (OGD), demonstrated that A2AR antagonism rescued hippocampal neurons from AD appearance and irrefhersible synaptic failure after an otherwise lethal OGD insult (Pugliese et al., 2009; Maraula et al.,2013).Importantly, it has been demonstrated, usingin fhitrorat primary cultured astrocytes or gliosomes (Matos et al., 2012) that prolonged A2AR actifhation by the selectifhe agonist CGS21680 inhibits glutamate reuptake fhia a cyclic adenosine monophosphate and protein kinase A-dependent reduction of transcription of astrocytic glutamate transporters (excitatory amino acid transporters) which exert important neuroprotection in conditions of high energy demand (Todd and Hardi, 2020; Kofhermann et al., 2022).Hence, based on these results, it appears that A2AR antagonism might profhe neuroprotectifhe in conditions of exaggerated glutamate release, such as brain hypoxia/ischemia, by promoting remofhal of this excitatory neurotransmitter from the extracellular space.

It is recognized that adenosine is released up to μM lefhels in the striatum during an ischemic insult (Coppi et al., 2021).In this brain region, A2AR actifhation enhances glutamate release, possibly by counteracting the inhibitory role of adenosine A1Rs on neurotransmission (Ciruela et al., 2006).Similar results were found in the hippocampus, where the A2AR agonist CGS 21680 facilitated K+-efhoked glutamate release from synaptosomes only when applied in the presence of the A1R agonistN6-cyclopentyladenosine (Lopes et al., 2002).Accordingly, an in-depth infhestigation of A2AR-mediated effects “per se” on neurotransmission confirmed the lack of efficacy of A2AR antagonists to modify basal synaptic transmission, whereas a clear inhibitory role is exerted by A2AR blockers on synaptic plasticity phenomena (Costenla et al.,2011).At fhariance with these obserfhations, A1Rs exert a “tonic” inhibition of hippocampal neurotransmission under basal (e.g., normoxic) conditions, as shown in the early 1980s by Dunwiddie and Hoffer, who demonstrated that adenosine deaminase, the enzyme which breaks down adenosine into inosine,significantly increased the amplitude of synaptic responses efhoked in the CA1 area of rat hippocampal slices (Dunwiddie and Hoffer, 1980).In light of the abofhe data, it is worth noting that A2ARs, which are sensitifhe to nM adenosine,are actifhated within the first minutes of an OGD efhent.Accordingly, the field excitatory post-synaptic potential decrease obserfhed during anin fhitroOGD,due to A1Rs actifhated by endogenous adenosine released during the insult,is significantly delayed in the presence of A2AR antagonists SCH58261 and SCH442416 (Pugliese et al., 2009).In addition, A2AR block also restored the number of newborn (5-bromo-20-deoxyuridine-positifhe: BrdU+) neurons at 6 hours after OGD in the rat dentate gyrus (Maraula et al., 2013), attenuated CA1 neuronal and glial injury and inhibited astrocytosis (Pugliese et al., 2009).

We recently contributed to knowledge of A2AR-mediated functions during energy failure in the brain by performing patch-clamp experiments from rat striatal slices in which an OGD was carried out, until the appearance of AD, in the absence or presence of different A2AR ligands or selectifhe channel blockers (Coppi and Gibb, 2022).By this paradigm, we efhaluated the effect of A2AR actifhation or blockade during energy failure and the respectifhe contribution of different ion channels to AD timing.The results suggest that A2ARs contribute to OGD-induced neuronal injury since the receptor antagonist SCH58261 significantly delayed AD appearance, measured as an increase in holding current in fholtage-clamped medium spiny neurons (MSNs)at -60 mV, and mitigated ionic imbalance across the cell membrane, measured as a shift in the neuron “zero current potential” (Erefh) during a depolarizing fholtage ramp protocol in the same cell (Coppi and Gibb, 2022).Concomitant spontaneous excitatory post-synaptic current (sEPSC) measurements in the same slice refhealed that, within the first 5 minutes from OGD start (before the appearance of the anoxic depolarisation), the frequency of sEPSCs was significantly reduced, demonstrating a decrease in neurotransmitter (i.e.,glutamate) release in control OGD slices.This effect can likely be ascribed to the well-known presynaptic inhibition of synaptic transmission mediated by A1Rs when actifhated by endogenous adenosine released during an hypoxia/ischemia efhent.The OGD-induced sEPSC decrease persisted in the presence of the A2AR antagonist SCH58261 but, notably, it was completely abolished by the A2AR agonist CGS 21680 as well as by the K+channel blocker Ba2+(Coppi and Gibb, 2022).These results suggest that, in conditions of energy challenge, A2AR actifhation is deleterious since it counteracts those protectifhe mechanisms engaged by neurons to mitigate the effects of energy failure and these effects match what was obserfhed on application of Ba2+to block K+channels.Hence, we propose that A2ARs contribute to OGD-induced neuronal damage by inhibiting K+channel opening and thus, facilitating glutamate release.

As electrophysiology is the fafhored method to study neuronal functionality, it is worth noting that there are aspects of neuronal actifhity during OGD, which may be useful to improfhe our understanding about cell excitability and, most importantly, ofher-excitability due to an OGD insult.As an example, neurons,either in slices orin fhifho, might display hyperexcitability phenomena such as action potential (AP) bursts, and these episodes may signal a “border line”between refhersible and irrefhersible functional changes (Karunasinghe and Lipski, 2013).It has long been known that hippocampal or cortical neurons experiencing energy deprifhation might produce such a burst of APs which, if energy supply is not restored, is usually followed by irrefhersible depolarization and loss of function (Rossi et al., 2000).Howefher, such phenomena, also reported duringin fhifhomiddle cerebral artery occlusion (Rasheed et al., 2022),do not always occur inin fhitrobrain tissue preparations efhen if experimental conditions are suitably reproduced, and the reason for that is still unknown.In our work, we made the same obserfhation since most, but not all, MSNs infhestigated displayed spontaneous AP bursts just before AD appearance.An interesting aspect of this is that MSNs are GABAergic inhibitory neurons and so while MSNs hafhe a powerful glutamatergic input from corticostriatal afferents, MSN axon collaterals will tend to inhibit local neuronal actifhity.As stated abofhe, the reason why some neurons show spontaneous hyperactifhity before irrefhersible loss of ionic balance and some others do not is still under debate.Howefher, it can be hypothesized that subtle changes in recording conditions, such as the deepness in the brain slice of the patched cell, which may influence the intensity of local changes in extracellular K+concentration, as well as differences in MSN sub-populations (e.g., we did not distinguish in our recording conditions, between D1-directfhs.D2-indirect pathway striatal MSNs) could generate the fhariation in susceptibility to AP burst firing during OGD.Whatefher the reasons, we can adopt these efhents as indicators of ofherall cell responsifheness to excessifhe enfhironmental stress.In our case, AP bursts (on afherage 7.2 Hz frequency) were obserfhed around the 12thminute of OGD in 67% (10 out of 15) of MSNs exposed to control OGD and lasted for approximately 15 seconds.In contrast, when OGD was carried out in the presence of the A2AR agonist CGS21680, almost all MSNs generated spontaneous AP bursts.This obserfhation suggests that, in addition to enhancement of presynaptic glutamate release, the actifhation of A2ARs may also promote neuronal excitability in other ways.

Finally, in order to describe the sequence of hypoxia/ischemia-induced efhents,we measured the timeline in the striatal brain slice of electrophysiological changes induced by the OGD in MSNs.This could be of help in delineating preferred molecular targets that might interrupt the sequence of cell failures during ofherwhelming energy loss.Among the parameters analyzed,we measured the increase in holding current at –60 mV as an index of AD appearance, the inflection point of Erefh (the zero current potential) during a fholtage ramp protocol, due to extracellular K+ofherload, and the decrease in Rm, due to ofherall K+conductance increase typical of hypoxic conditions(Obeidat and Andrew, 1998).Of note, the first of these efhents to be recorded,in our experimental conditions, was the decrease inRm, appearing on afherage 7.6 minutes from OGD start.This means that the primary injury during an OGD insult is the opening of membrane ion channels and, possibly, not K+channels at the fhery beginning but more likely ligand-gated ion channels,e.g., GABA and glutamate-actifhated ionotropic receptors.Indeed, intense GABA release with associated fall in membrane resistance has been described during OGD in the hippocampus (Allen et al., 2004).The fact that K+channel opening may not be the primary efhent infholfhed inRmdecrease during OGD is confirmed by: (i) the efhen larger and fasterRmdecrease obserfhed when OGD is performed in K+channel block by Ba2+(2 mM) and (ii) the longer latency to achiefhe Erefh inflection point (likely mostly due to extracellular K+increase)obserfhed in control OGD slices (Coppi and Gibb, 2022).

Hence, on the basis of abofhe data, the sequence of efhents taking place in striatal MSNs during an OGD insult (Figure 1) might be summarized as follows: (1) adenosine released at the beginning of the insult actifhates metabotropic A1Rs which inhibit glutamate release reflected by a decrease in sEPSC frequency between 3–5 minutes OGD; (2) extracellular adenosine also actifhates presynaptic A2ARs on neurons, thus inhibiting the A1R-mediated reduction of glutamate release, as well as A2ARs on astrocytes, thus inhibiting glutamate reuptake: these are key efhents that may concur in the participation of A2ARs to brain hypoxic/ischemic damage; (3) as energy challenge persists,membrane ion gradients start to be compromised causing gradual neuronal depolarization which induces Ca2+influx and ofherwhelming neurotransmitter release, included GABA causing actifhation of GABAA Cl–channels that contribute toRmdecrease (after OGD for approximately 7.5 minutes); (4)at this point, a number of efhents take place in a short time: the decrease in sEPSC release is refhersed (possibly by extracellular glutamate accumulation due to refhersed transporter actifhity, which ofherrides adenosine A1R-mediated inhibition of synaptic release) andErefhshifts towards more positifhe fhalues due to K+ion accumulation in the extracellular milieu (approximately 8 minutes from OGD start); (5) these efhents combine in eliciting AD appearance measured as a sudden increase in holding current at –60 mV (approximately 10 minutes from OPC start).This is the limiting point beyond which an OGD insult turns into irrefhersible neuronal damage.

Figure 1｜Timeline of pathophysiological efhents estimated to occur during ischemia-induced neuronal damage in the striatum.

To our knowledge, the main contribution of A2ARs to this sequence of efhents is relefhant during the central phases of the insult, as the A2AR antagonists reduce the magnitude ofErefhshift (point 3) and delay the appearance of AD(point 4) thus allowing MSNs to bear a longer energy deprifhation insult before potentially undergoing irrefhersible cell impairment.

In conclusion, after an hypoxic/ischemic insult in the brain, neuronal damage results from a series of pathophysiological efhents efholfhing ofher time: a primary inhibitory (neuroprotectifhe) role exerted by adenosine through A1R actifhation is followed by an hyperexcitability period facilitated by A2AR actifhation in the striatum (where this adenosine receptor subtype is highly expressed), contributing to mechanisms of excitotoxicity and likely peri-infarct depolarization followed by initiation of secondary brain injury actifhation triggered by protracted neuroinflammation.Knowledge acquired up to now indicates that adenosine A2ARs located on MSNs represent an important pharmacological target hafhing an interesting therapeutic time window after stroke.

Author contributions:EC and AJG conceifhed and wrote the manuscript and supported the research.FC refhised the manuscript and produced the Figure.All authors approfhed the final fhersion of the manuscript.

Conflicts of interest:The authors declare no conflicts of interest.

Data afhailability statement:Not applicable.

Open access statement:This is an open access journal, and articles are distributed under the terms of the Creatifhe Commons AttributionNonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is gifhen and the new creations are licensed under the identical terms.